Effect of liposomes and niosomes on skin permeation of enoxacin

被引:221
作者
Fang, JY
Hong, CT
Chiu, WT
Wang, YY
机构
[1] Taipei Med Univ, Grad Inst Pharmaceut Sci, Taipei, Taiwan
[2] Taipei Med Univ, Taipei Municipal Wan Fang Hosp, Dept Neurol, Taipei, Taiwan
[3] Taipei Med Univ, Taipei Municipal Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan
[4] Mackay Mem Hosp, Dept Pharmaceut, Taipei, Taiwan
关键词
enoxacin; liposomes; niosomes; skin permeatiom;
D O I
10.1016/S0378-5173(01)00627-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The skin permeation and partitioning of a fluorinated quinolone antibacterial agent, enoxacin, in liposomes and niosomes, after topical application, were elucidated in the present study. In vitro percutaneous absorption experiments were performed on nude mouse skin with Franz diffusion cells. The influence of vesicles on the physicochemical property and stability of the formulations were measured. The enhanced delivery across the skin of liposome and niosome encapsulated enoxacin had been observed after selecting the appropriate formulations. The optimized formulations could also reserve a large amount of enoxacin in the skin. A significant relationship between skin permeation and the cumulative amount of enoxacin in the skin was observed. Both permeation enhancer effect and direct vesicle fusion with stratum corneum may contribute to the permeation of enoxacin across skin. Formulation with niosomes demonstrated a higher stability after 48 h incubation compared to liposomes. The inclusion of cholesterol improved the stability of enoxacin liposomes according to the results from encapsulation and turbidity. However, adding negative charges reduced the stability of niosomes. The ability of liposomes and niosomes to modulate drug delivery without significant toxicity makes the two vesicles useful to formulate topical enoxacin. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:61 / 72
页数:12
相关论文
共 30 条
[21]   Enhancement of percutaneous absorption of naproxen by phospholipids [J].
Valjakka-Koskela, R ;
Kirjavainen, M ;
Mönkkönen, J ;
Urtti, A ;
Kiesvaara, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 175 (02) :225-230
[22]   INVITRO INTERACTION OF SIZED AND UNSIZED LIPOSOME VESICLES WITH HIGH-DENSITY LIPOPROTEINS [J].
VEMURI, S ;
YU, CD ;
DEGROOT, JS ;
ROOSDORP, N .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (09) :1579-1584
[23]  
Vemuri S, 1995, Pharm Acta Helv, V70, P95, DOI 10.1016/0031-6865(95)00010-7
[24]   LATERAL ORGANIZATION OF LIQUID-CRYSTALLINE CHOLESTEROL-DIMYRISTOYLPHOSPHATIDYLCHOLINE BILAYERS - EVIDENCE FOR DOMAINS WITH HEXAGONAL AND CENTERED RECTANGULAR CHOLESTEROL SUPERLATTICES [J].
VIRTANEN, JA ;
RUONALA, M ;
VAUHKONEN, M ;
SOMERHARJU, P .
BIOCHEMISTRY, 1995, 34 (36) :11568-11581
[25]   Proniosome based transdermal delivery of levonorgestrel for effective contraception [J].
Vora, B ;
Khopade, AJ ;
Jain, NK .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (02) :149-165
[26]  
VULTA NB, 1996, J PHARM SCI, V85, P5
[27]   TOPICAL DELIVERY OF LIPOSOMALLY ENCAPSULATED INTERFERON EVALUATED IN A CUTANEOUS HERPES GUINEA-PIG MODEL [J].
WEINER, N ;
WILLIAMS, N ;
BIRCH, G ;
RAMACHANDRAN, C ;
SHIPMAN, C ;
FLYNN, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1217-1221
[28]   Effect of phosphatidylcholine on the percutaneous penetration of drugs through the dorsal skin of guinea pigs in vitro; And analysis of the molecular mechanism, using attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy [J].
Yokomizo, Y .
JOURNAL OF CONTROLLED RELEASE, 1996, 42 (03) :249-262
[29]   PREPARATION AND PROPERTIES OF VESICLES (NIOSOMES) OF SORBITAN MONOESTERS (SPAN-20, SPAN-40, SPAN-60 AND SPAN-80) AND A SORBITAN TRIESTER (SPAN-85) [J].
YOSHIOKA, T ;
STERNBERG, B ;
FLORENCE, AT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 105 (01) :1-6
[30]   CLINICAL OVERVIEW OF ENOXACIN [J].
ZINNER, SH .
CLINICAL PHARMACOKINETICS, 1989, 16 :59-64